MedTrace Logo

Are There Any Clinical Benefits to Screening for Late -Onset Gestational Diabetes Mellitus?"

NCT07776314 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2026-08-20

No results posted yet for this study

Summary

This study aims to screen women who have a negative Gestational diabetes mellitus (GDM) result in routine screening tests or who have never had it with the Fasting Blood Glucose Test (FBG) at 32-34 weeks of gestation to diagnose late-onset GDM with routine FBG ≥5.1 mmol/L (92mg/dl) in fasting blood, and to investigate its connection with perinatal and maternal outcomes, hoping to inform about late-stage GDM.

Conditions

  • Pregnancy in Diabetes
  • Pregnancy
  • Pregnancy Outcomes

Sponsors & Collaborators

  • Izmir Ataturk Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-13
Primary Completion
2026-09-01
Completion
2026-11-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07776314 on ClinicalTrials.gov